{
  "image_filename": "table_p8_det_7_002.png",
  "image_path": "Hsiao_et_al.__2023_/extracted/figures/table_p8_det_7_002.png",
  "image_type": "Table",
  "page_number": 8,
  "block_id": "det_7_002",
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "supports_claim": false,
  "explanation": "A table presenting clinical outcomes comparing two vaccine groups (N=279,400 vs. N=395,852). Outcomes include incidence of PCR-confirmed influenza (overall, type A, type B), hospitalizations for PCR-confirmed influenza, community-acquired pneumonia, and cardiorespiratory events, with columns for unadjusted rate ratio, hazard ratio (95% CI), effectiveness (95% CI), and P values. The table presents comparative effectiveness and clinical outcome data for two vaccine groups but contains no information on antigenic matching or alignment with WHO- or FDA-selected influenza strains; it does not support the claim.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table presenting clinical outcomes comparing two vaccine groups (N=279,400 vs. N=395,852). Outcomes include incidence of PCR-confirmed influenza (overall, type A, type B), hospitalizations for PCR-confirmed influenza, community-acquired pneumonia, and cardiorespiratory events, with columns for unadjusted rate ratio, hazard ratio (95% CI), effectiveness (95% CI), and P values.",
    "evidence_found": null,
    "reasoning": "The table presents comparative effectiveness and clinical outcome data for two vaccine groups but contains no information on antigenic matching or alignment with WHO- or FDA-selected influenza strains; it does not support the claim.",
    "confidence_notes": null
  }
}